News on Adamastor Bioservices
Adamastor x DTI-Tech
June, 2026
Adamastor Bioservices announces a strategic collaboration with DTI-Tech, a Swiss company specialised in drug target identification through advanced proteomics.
The partnership integrates target identification with quantitative binding characterisation, providing a complete workflow from target discovery to biophysical validation.
See the press release.
London Lab Live
May, 2026
Adamastor Bioservices was featured in the Startup Area at London Lab Live, held at ExCeL London.
During the event, the team had the opportunity to discuss science, innovation, and new collaboration opportunities in drug discovery, molecular interactions, and real-time technologies.
Interreg project ITCH-AMP
March, 2026
Adamastor Bioservices reports the launch of the ITCH-AMP project under the Interreg Italy–Switzerland programme, following the kick-off meeting held in Sion and Monthey (Switzerland).
The consortium brings together the University of Eastern Piedmont, Precise Health SA, Adamastor Bioservices Srl, and associated partners BioArk and HES-SO Valais-Wallis.
The project addresses the challenge of antimicrobial resistance (AMR) through a multidisciplinary approach combining phage therapy, engineered proteins, binding kinetics studies, and AI-driven methodologies.
CIR Certification
December, 2025
Adamastor BioServices is pleased to announce that it has obtained the CIR (Crédit d’Impôt Recherche) certification from the French Ministry of Higher Education and Research.
Thanks to this certification, our French clients can benefit from a research tax credit for projects carried out in collaboration with us.
Festival of Biologics in Basel
September, 2025
We exhibited at the Festival of Biologics in Basel in the startup area, presenting our services to the international biologics and biopharma community.
It was a great opportunity to meet industry professionals, strengthen collaborations, and explore new potential partnerships.
New independent lab in Magenta
August, 2025
We are pleased to announce the opening of our new laboratory in Magenta.
This milestone gives us greater autonomy and flexibility, allowing us to work more efficiently and better support our clients and partners.
Kinetics2025 at Institut Pasteur
March, 2025
At the Kinetics 2025 course at Institut Pasteur, part of the MOSBRI Project’s Advanced Level Schools, we had the opportunity to provide hands-on training with LigandTracer to experienced researchers and share our expertise in real-time cell binding assays.
The lab is set! Here we go...
October, 2024
Is with great pleasure that we announce that our lab is set for providing our services.
We are looking forward to start working with you and bring more solutions for the drug development in neurodegenerative and inflammatory diseases.
Our website is on-line
September, 2024
We are thrilled to present our website, where you can get to know more about us and our mission, the kind of services that we provide and be updated by our latest news.
Feel free to use our contact form to get more information about our services.
We had the chance to talk about real-time cell binding assays
June, 2024
It was a pleasure to participate and sponsor the recent Advanced school on biophysical methods for protein-protein and protein-ligand interaction.
The event showcased an incredible combination of biophysical technologies for drug development, providing a platform to explore groundbreaking scientific advancements.
Meeting and connecting with so many experts and young scientists was truly inspiring. We are looking forward to more collaborations and innovations in the future!